Clinical Trial Update: Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC. [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial evaluating induction immunochemotherapy followed by concurrent chemoradiotherapy in patients with esophageal squamous cell carcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Esophageal Cancer | Phase 2 | Status: RECRUITING